Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.

Zhu CB, Hewlett WA, Francis SH, Corbin JD, Blakely RD
Eur J Pharmacol. 2004 504 (1-2): 1-6

PMID: 15507214 · DOI:10.1016/j.ejphar.2004.09.023

The serotonin (5-hydroxtryptamine, 5-HT) transporter (SERT) plays a critical role in the inactivation of synaptic 5-HT and has been implicated in multiple psychiatric and peripheral disorders. SERT regulation studies demonstrate that activation of cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG)-linked pathways can increase SERT activity. As cGMP actions are limited by cGMP-specific phosphodiesterase (PDEs), we investigated whether the cGMP-specific PDE5 inhibitor sildenafil (Viagra) can stimulate 5-HT uptake and potentiate cGMP-mediated regulation. In RBL-2H3 cells, SERT activity was stimulated by sildenafil in a concentration- and time-dependent manner. Sildenafil also enhanced the stimulation of SERT triggered by the adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine (NECA), effects blocked by the PKG inhibitor N-[2-(methylamino)ethy]-5-isoquinoline-sulfonamide (H8). Sildenafil stimulation of 5-HT uptake arises from an increase in 5-HT transport Vmax and is paralleled by elevated SERT surface antagonist binding, also H8-sensitive. These findings implicate cGMP-targeted PDEs in limiting the regulation of antidepressant-sensitive 5-HT transport.

MeSH Terms (17)

3',5'-Cyclic-GMP Phosphodiesterases Animals CHO Cells Cricetinae Cyclic Nucleotide Phosphodiesterases, Type 5 Membrane Glycoproteins Membrane Transport Proteins Nerve Tissue Proteins Phosphodiesterase Inhibitors Piperazines Protein Binding Purines Rats Serotonin Serotonin Plasma Membrane Transport Proteins Sildenafil Citrate Sulfones

Connections (2)

This publication is referenced by other Labnodes entities: